Search

Your search keyword '"Menéndez‐González, M."' showing total 118 results

Search Constraints

Start Over You searched for: Author "Menéndez‐González, M." Remove constraint Author: "Menéndez‐González, M."
118 results on '"Menéndez‐González, M."'

Search Results

2. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

3. Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort

4. New insights into the genetic etiology of Alzheimer's disease and related dementias

7. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

8. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort

9. Embracing monogenic Parkinson's disease: the MJFF Global Genetic PD cohort

10. New insights into the genetic etiology of Alzheimer's disease and related dementias

11. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

12. Predictors of clinically significant quality of life impairment in Parkinson's disease

13. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

14. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

16. Perrault syndrome with neurological features in a compound heterozygote for two TWNK mutations: overlap of TWNK-related recessive disorders

17. Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset

18. Using global team science to identify genetic Parkinson's disease worldwide

19. The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight

20. Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort

21. Implantable Systems for Continuous Liquorpheresis and CSF Replacement

22. Manual Planimetry of the Medial Temporal Lobe Versus Automated Volumetry of the Hippocampus in the Diagnosis of Alzheimer's Disease

23. Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab

28. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort

29. Assessing the association between common functional Nuclear Factor Kappa-b gene polymorphisms (NFKB1, NFKBIZ, NFKBIA) and Alzheimer´s disease.

30. NFKB1 variants were associated with the risk of Parkinson´s disease in male.

31. Huntingtin CAG repeats in neuropathologically confirmed tauopathies: Novel insights.

32. Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study.

33. Influence of manipulative skills on quality of life and activities of daily living in multiple sclerosis.

34. An Insertion Within SIRPβ1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response.

35. Staging Parkinson's disease according to the MNCD classification correlates with caregiver burden.

36. Cognitive impairment and dementia in young onset Parkinson's disease.

37. A Nanostructured Protein Filtration Device for Possible Use in the Treatment of Alzheimer's Disease-Concept and Feasibility after In Vivo Tests.

38. Refining Stereotaxic Neurosurgery Techniques and Welfare Assessment for Long-Term Intracerebroventricular Device Implantation in Rodents.

39. Toward a new nosology of neurodegenerative diseases.

40. Mechanical filtration of the cerebrospinal fluid: procedures, systems, and applications.

41. Sex Differences in Motor and Non-Motor Symptoms among Spanish Patients with Parkinson's Disease.

42. Mendelian Randomisation Confirms the Role of Y-Chromosome Loss in Alzheimer's Disease Aetiopathogenesis in Men.

43. Changes in Principal Caregiver Mood Affects the Mood of the Parkinson's Disease Patient: The Vicious Cycle of Illness.

44. Falls Predict Acute Hospitalization in Parkinson's Disease.

45. Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life.

47. New, Fully Implantable Device for Selective Clearance of CSF-Target Molecules: Proof of Concept in a Murine Model of Alzheimer's Disease.

48. The "Cerebrospinal Fluid Sink Therapeutic Strategy" in Alzheimer's Disease-From Theory to Design of Applied Systems.

49. Smoking is associated with age at disease onset in Parkinson's disease.

50. Genomic Characterization of Host Factors Related to SARS-CoV-2 Infection in People with Dementia and Control Populations: The GR@ACE/DEGESCO Study.

Catalog

Books, media, physical & digital resources